MarketResearchReports.Biz

lobalDatas new report, "United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the United States In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

View Full Report at http://www.marketresearchreports.biz/analysis/483472

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Download Sample Copy of this Report at http://www.marketresearchreports.biz/sample/sample/483472

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for In Vitro Diagnostics market.
- Global corporate-level profiles of key companies operating within the United States In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.